https://secretometherapeutics.com/2015/04/cardiosphere-derived-cells-from-pediatric-end-stage-heart-failure-patients-have-enhanced-functional-activity-due-to-the-heat-shock-response-regulating-the-secretome/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2018/04/regenerative-medicine-therapy-for-single-ventricle-congenital-heart-disease/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2017/03/a-deep-proteome-analysis-identifies-the-complete-secretome-as-the-functional-unit-of-human-cardiac-progenitor-cells/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2012/09/a-strong-regenerative-ability-of-cardiac-stem-cells-derived-from-neonatal-hearts/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2015/08/stem-cell-therapy-for-congenital-heart-disease-toward-translation/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2018/01/the-current-status-and-future-of-cardiac-stem-progenitor-cell-therapy-for-congenital-heart-defects-from-diabetic-pregnancy/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2014/06/celastrol-an-oral-heat-shock-activator-ameliorates-multiple-animal-disease-models-of-cell-death/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2011/02/characterization-and-functionality-of-cardiac-progenitor-cells-in-congenital-heart-patients/ 2022-10-03T05:28:34+00:00 https://secretometherapeutics.com/2015/08/pediatric-end-stage-failing-hearts-demonstrate-increased-cardiac-stem-cells/ 2022-10-03T06:35:58+00:00 https://secretometherapeutics.com/2018/07/stem-cell-therapy-for-hypoplastic-left-heart-syndrome-mechanism-clinical-application-and-future-directions/ 2022-10-03T06:38:43+00:00 https://secretometherapeutics.com/2019/05/circulating-exosomes-derived-from-transplanted-progenitor-cells-aid-the-functional-recovery-of-ischemic-myocardium/ 2022-10-03T06:42:55+00:00 https://secretometherapeutics.com/2017/03/young-hearts-run-free-therapeutic-potential-of-neonatal-human-cardiac-progenitor-cells-secretome/ 2022-10-03T07:11:35+00:00 https://secretometherapeutics.com/2022/06/comparative-efficacy-and-mechanism-of-action-of-cardiac-progenitor-cells-after-cardiac-injury/ 2022-10-03T07:19:13+00:00 https://secretometherapeutics.com/2023/05/secretome-therapeutics-presents-scientific-poster-on-the-essential-role-of-complete-secretome-in-regenerative-cell-therapy-at-isscr-2023-annual-meeting/ 2023-05-16T23:26:14+00:00 https://secretometherapeutics.com/2024/10/secretome-therapeutics-inc-announces-composition-of-matter-patents-for-lead-assets-stm-01-and-stm-21/ 2024-11-09T18:44:55+00:00 https://secretometherapeutics.com/2025/01/cellipont-bioservices-and-secretome-therapeutics-partner-for-cgmp-manufacturing-for-master-cell-bank-for-lead-asset-stm-01/ 2025-02-25T14:31:08+00:00 https://secretometherapeutics.com/2024/09/hest-investments-leads-1-8-million-spv-investment-in-secretome-therapeutics-to-advance-human-trials/ 2025-02-25T14:36:48+00:00 https://secretometherapeutics.com/2024/11/secretome-therapeutics-closes-20-4-million-financing-round-to-advance-cardiomyopathy-and-heart-failure-therapies/ 2025-02-25T14:47:25+00:00 https://secretometherapeutics.com/2023/07/secretome-therapeutics-appoints-margot-connor-as-board-director-and-assembles-world-class-clinical-advisory-board/ 2025-02-25T14:48:44+00:00 https://secretometherapeutics.com/2025/03/secretome-therapeutics-granted-fda-fast-track-designation-for-stm-01-a-neonatal-cardiac-progenitor-cell-therapy-for-hfpef/ 2025-03-25T13:31:45+00:00 https://secretometherapeutics.com/2025/03/secretome-therapeutics-announces-first-patient-dosed-in-groundbreaking-phase-1-study-of-stm-01-in-heart-failure-with-preserved-ejection-fraction/ 2025-03-25T13:32:52+00:00 https://secretometherapeutics.com/2025/04/secretome-therapeutics-appoints-dr-marshelle-smith-warren-as-chief-medical-officer/ 2025-04-23T15:30:37+00:00 https://secretometherapeutics.com/2025/10/roosterbio-and-secretome-therapeutics-announce-successful-completion-of-large-scale-bioreactor-production-for-clinical-stage-cell-therapy-candidate-stm-01/ 2026-02-23T03:32:16+00:00 https://secretometherapeutics.com/2025/12/secretome-therapeutics-to-present-at-the-2026-j-p-morgan-healthcare-conference/ 2026-03-03T17:07:11+00:00 https://secretometherapeutics.com/2025/10/secretome-therapeutics-initiates-phase-1-clinical-trial-of-stm-01-in-patients-with-dilated-cardiomyopathy/ 2026-03-06T17:54:38+00:00 https://secretometherapeutics.com/2025/09/secretome-therapeutics-awarded-400000-grant-from-friedreichs-ataxia-research-alliance-fara/ 2026-03-06T19:10:49+00:00 https://secretometherapeutics.com/2026/03/ppmd-provides-250000-in-funding-to-secretome-therapeutics-through-ppmd-venture-pathways-program-to-support-development-of-cardiac-cell-therapy/ 2026-03-24T19:36:33+00:00